Chemotherapy plus immunotherapy improves survival in patients with metastatic urothelial cancer

Chemotherapy plus immunotherapy improves survival in patients with metastatic urothelial cancer
A clinical trial co-led by Mount Sinai researchers is the first to show that using chemotherapy with immunotherapy resulted in improved survival in patients wit...
A clinical trial co-led by Mount Sinai researchers is the first to show that using chemotherapy with immunotherapy resulted in improved survival in patients wit... Read More



Related Stories

See All